Last $73.90 USD
Change Today +2.33 / 3.26%
Volume 455.5K
INCY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 3:50 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard S. Levy M.D.

Chief Drug Development & Medical Officer and Executive Vice President, Incyte Corporation
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 2 different industries.

See Board Relationships
56$1,688,526
As of Fiscal Year 2013

Background*

Dr. Richard S. Levy, M.D. has been the Chief Drug Development Officer & Medical Officer and Executive Vice President of Incyte Corporation since January 2009. Dr. Levy served as the Senior Vice President of Drug Development of Incyte Corporation since August 26, 2003. He has over 12 years of experience in the pharmaceutical and biotechnology sectors through his prior positions at Celgene, DuPont Pharmaceuticals and Novartis. Most recently, he served as Vice President ...

Read Full Background

Corporate Headquarters*

Experimental Station
Wilmington, Delaware 19880

United States

Phone: 302-498-6700
Fax: --

Board Members Memberships*

2014-Present
Non-Executive Director

Education*

MD
The University of Pennsylvania
BA
Brown University

Other Affiliations*

Annual Compensation*

Salary$373,423
Total Annual Compensation$373,423

Stock Options*

All Other Compensation$6,664
Exercised Options183,440
Exercised Options Value$3,096,618
Exercisable Options406,110
Exercisable Options Value$15,921,874
Unexercisable Options188,890
Unexercisable Options Value$6,132,176
Total Value of Options$25,150,668
Total Number of Options778,440

Total Compensation*

Total Annual Cash Compensation$646,020
Total Short Term Compensation$373,423
Other Long Term Compensation$6,664
Total Calculated Compensation$1,688,526
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $73.90 USD +2.33

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Werner Lanthaler MBA,MPAChief Executive Officer
Evotec AG
€601.0K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$552.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.